Filters: Keyword is Hepatitis C [Clear All Filters]
"Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population." American journal of public health 104, no. 9 (2014): 1713-21. Abstract
"Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort." AIDS (London, England) 20, no. 3 (2006): 323-31. Abstract
"A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice." Expert review of clinical pharmacology 6, no. 3 (2013): 249-69. Abstract
"Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases." The American journal of drug and alcohol abuse 33, no. 6 (2007): 869-74. Abstract
"Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication." The American journal of drug and alcohol abuse 38, no. 3 (2012): 206-12. Abstract
"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection." Hepatology (Baltimore, Md.) 40, no. 1 (2004): 115-9. Abstract
"Rate and predictors of treatment prescription for hepatitis C." Gut 56, no. 3 (2007): 385-9. Abstract
"Hepatitis C virus infection and the risk of coronary disease." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 2 (2009): 225-32. Abstract
"The HIV epidemic in Eastern Europe and Central Asia." Current HIV/AIDS reports 11, no. 2 (2014): 168-76. Abstract
"Hepatitis C and the risk of kidney disease and mortality in veterans with HIV." Journal of acquired immune deficiency syndromes (1999) 53, no. 2 (2010): 222-6. Abstract
"The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C." Circulation. Cardiovascular quality and outcomes 4, no. 4 (2011): 425-32. Abstract
"Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis." Journal of acquired immune deficiency syndromes (1999) 55 Suppl 1 (2010): S37-42. Abstract
"Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 8 (2003): 1039-46. Abstract
"Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans." AIDS (London, England) 19 Suppl 3 (2005): S99-105. Abstract
"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place." American journal of epidemiology 168, no. 10 (2008): 1099-109. Abstract
"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities." The Journal of infectious diseases 201, no. 3 (2010): 378-85. Abstract
"Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens." The Journal of infectious diseases 173, no. 4 (1996): 997-1000. Abstract
"CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users." The Journal of infectious diseases 201, no. 5 (2010): 730-9. Abstract
"Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users." Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 30 (2015): 175-80. Abstract
"A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups." Social science & medicine (1982) 68, no. 3 (2009): 579-90. Abstract
"Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 47, no. 7 (2008): 952-61. Abstract
"Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration." Journal of acquired immune deficiency syndromes (1999) 69, no. 3 (2015): 348-54. Abstract
"Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24, no. 31 (2006): 5005-9. Abstract
"The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting." PloS one 8, no. 5 (2013): e64321. Abstract
"Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection." Addiction (Abingdon, England) 104, no. 11 (2009): 1881-90. Abstract
"Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas." Journal of urban health : bulletin of the New York Academy of Medicine 89, no. 3 (2012): 527-64. Abstract
"The HCV Synthesis Project: scope, methodology, and preliminary results." BMC medical research methodology 8 (2008): 62. Abstract
"Writing about risk: use of daily diaries in understanding drug-user risk behaviors." AIDS and behavior 8, no. 1 (2004): 73-85. Abstract
"Hepatitis C and HIV infections: implications for clinical care in injection drug users." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 1 (2004): 1-20. Abstract
"Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance." The Journal of infectious diseases 193, no. 3 (2006): 455-7. Abstract
"High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia." International journal of STD & AIDS 18, no. 1 (2007): 41-6. Abstract
